| 1 |
Idres YM, Lai AJ, McMillan NAJ, Idris A. Hyperactivation of p53 using CRISPRa kills human papillomavirus-driven cervical cancer cells. Virus Genes 2023;59:312-6. [PMID: 36474086 DOI: 10.1007/s11262-022-01960-2] [Reference Citation Analysis]
|
| 2 |
Zhan YR, Chen P, He X, Hei MW, Zhang J, Yu XQ. Sodium Alginate-Doping Cationic Nanoparticle As Dual Gene Delivery System for Genetically Bimodal Therapy. Biomacromolecules 2022;23:5312-21. [PMID: 36346945 DOI: 10.1021/acs.biomac.2c01119] [Reference Citation Analysis]
|
| 3 |
Li H, Zha S, Li H, Liu H, Wong KL, All AH. Polymeric Dendrimers as Nanocarrier Vectors for Neurotheranostics. Small 2022;18:e2203629. [PMID: 36084240 DOI: 10.1002/smll.202203629] [Reference Citation Analysis]
|
| 4 |
Idres YM, Lai A, Mcmillan N, Idris A. Hyperactivation of p53 using CRISPRa kills human papillomavirus driven cervical cancer cells.. [DOI: 10.21203/rs.3.rs-2015515/v1] [Reference Citation Analysis]
|
| 5 |
Drakopoulou E, Anagnou NP, Pappa KI. Gene Therapy for Malignant and Benign Gynaecological Disorders: A Systematic Review of an Emerging Success Story. Cancers 2022;14:3238. [DOI: 10.3390/cancers14133238] [Reference Citation Analysis]
|
| 6 |
Ganguly K, Jin H, Dutta SD, Patel DK, Patil TV, Lim K. Magnetic field-assisted aligned patterning in an alginate-silk fibroin/nanocellulose composite for guided wound healing. Carbohydrate Polymers 2022. [DOI: 10.1016/j.carbpol.2022.119321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Govindarasu M, Abirami P, Rajakumar G, Ansari MA, Alomary MN, Aba Alkhayl FF, Aloliqi AA, Thiruvengadam M, Vaiyapuri M. Kaempferitrin inhibits colorectal cancer cells by inducing reactive oxygen species and modulating PI3K/AKT signalling pathway. Process Biochemistry 2022. [DOI: 10.1016/j.procbio.2022.02.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Ghosh S, Jayaram P, Kabekkodu SP, Satyamoorthy K. Targeted drug delivery in cervical cancer: Current perspectives. Eur J Pharmacol 2022;917:174751. [PMID: 35021110 DOI: 10.1016/j.ejphar.2022.174751] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Salinas-Montalvo AM, Supramaniam A, McMillan NA, Idris A. RNA-based gene targeting therapies for human papillomavirus driven cancers. Cancer Lett 2021;523:111-20. [PMID: 34627949 DOI: 10.1016/j.canlet.2021.10.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 10 |
Wang X, Liu S, Guan Y, Ding J, Ma C, Xie Z. Vaginal drug delivery approaches for localized management of cervical cancer. Adv Drug Deliv Rev 2021;174:114-26. [PMID: 33857555 DOI: 10.1016/j.addr.2021.04.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 11 |
Tarach P, Janaszewska A. Recent Advances in Preclinical Research Using PAMAM Dendrimers for Cancer Gene Therapy. Int J Mol Sci 2021;22:2912. [PMID: 33805602 DOI: 10.3390/ijms22062912] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 12 |
Liu F, Chen B, Chen W, Chen S, Ma D, Xie M. Preparation of FA-targeted magnetic nanocomposites co-loading TFPI-2 plasmid and cis-platinum and its targeted therapy effects on nasopharyngeal carcinoma. Int J Med Sci 2021;18:2355-65. [PMID: 33967612 DOI: 10.7150/ijms.52643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Liu F, Lv RB, Liu Y, Hao Q, Liu SJ, Zheng YY, Li C, Zhu C, Wang M. Salinomycin and Sulforaphane Exerted Synergistic Antiproliferative and Proapoptotic Effects on Colorectal Cancer Cells by Inhibiting the PI3K/Akt Signaling Pathway in vitro and in vivo. Onco Targets Ther 2020;13:4957-69. [PMID: 32581555 DOI: 10.2147/OTT.S246706] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Áyen Á, Jiménez Martínez Y, Boulaiz H. Targeted Gene Delivery Therapies for Cervical Cancer. Cancers (Basel) 2020;12:E1301. [PMID: 32455616 DOI: 10.3390/cancers12051301] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 15 |
Doosti-Telgerd M, Mahdavi FS, Moradikhah F, Porgham Daryasari M, Bayrami Atashgah R, Dolatyar B, Akbari Javar H, Seyedjafari E, Shabani I, Arefian E, Najafi F, Abdi Y, Amini M. Nanofibrous Scaffolds Containing Hydroxyapatite and Microfluidic-Prepared Polyamidoamin/BMP-2 Plasmid Dendriplexes for Bone Tissue Engineering Applications. Int J Nanomedicine 2020;15:2633-46. [PMID: 32368045 DOI: 10.2147/IJN.S244416] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 16 |
Dong M, Chen J, Zhang J, Liang X, Yang J, Li D, Li Q. A chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated p53 gene delivery for achieving antitumor efficacy in prostate cancer. Int J Nanomedicine 2019;14:1149-61. [PMID: 30863051 DOI: 10.2147/IJN.S191905] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 17 |
Li J, Han Y, Lu Y, Song B, Zhao M, Hu H, Chen D. A novel disulfide bond-mediated cleavable RGD-modified PAMAM nanocomplex containing nuclear localization signal HMGB1 for enhancing gene transfection efficiency. Int J Nanomedicine 2018;13:7135-53. [PMID: 30464464 DOI: 10.2147/IJN.S182445] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
